Trial
NCT05127525
EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN)
Phase IIITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
iRenix Medical, Inc.
Collaborators
—
Condition
Diabetic Macular Edema
Intervention
IRX-101
Why stopped
Adverse event
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-05-24